Maps and diagnoses heart muscle diseases to guide earlier, targeted treatment
Studies adults with several types of cardiomyopathy, a heart muscle disease, to diagnose them.
Plain-language title generated from the registry record
Registry title: Sahlgrenska Cardiomyopathy Project
Key facts
- Where
- Gothenburg, SwedenSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a primary heart muscle disease (cardiomyopathy), including inflammation of the heart muscle, sarcoidosis or amyloidosis that affects the heart.
- Age
- 18 Years to 99 Years
- Sex
- All sexes can join.
- Disease stage
- Primary cardiomyopathy: dilated (hereditary or inflammatory), hypertrophic, restrictive, left ventricular non-compaction, arrhythmogenic right ventricular, myocarditis, giant cell myocarditis, sarcoidosis or amyloidosis involving the heart.
Main reasons for not taking part
- Other heart disease before the cardiomyopathy diagnosis, such as significant valve, ischemic or pericardial disease
- Under 18 years of age
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
Source: NCT03527342, who can take part
Where in Sweden
- Göteborg University, Sahlgrenska UniversitetssjukhusetGothenburg, SwedenNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Göteborg University
- Trial code
- NCT03527342
- Record updated
- 6 November 2018
- Original description
This is a joint project by Sahlgrenska University Hospital: Sahlgrenska, Östra and Mölndal.Read full original descriptionShow less
Sahlgrenska University Hospital Cardiomyopathy Project: Mapping and Diagnosis of Cardiomyopathies to Enable Early and Specific Treatment
This is a joint project by Sahlgrenska University Hospital: Sahlgrenska, Östra and Mölndal.
Our objective is to diagnose and map patients with well phenotyped cardiomyopathies (CMP) including in depth clinical and molecular phenotyping to enable earlier and specific treatment. The project will serve as:
1. resource for diagnostic and therapeutic trials 2. common biomaterial bank 3. resource for detailed molecular analyses on patients' biomaterials and patient specific symptoms and examination results
Inclusion: Patients with primary cardiomyopathies including hereditary and inflammatory dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, left ventricular non-compaction cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, myocarditis, giant cell myocarditis, sarcoidosis and amyloidosis engaging the heart.
Exclusion: Patient with other preexisting cardiac diseases such as significant valvular, ischemic or pericardial disease before they receive a cardiomyopathy diagnose; patients < 18 years.